VEGFA and retinopathy of prematurity: Both preclinical and clinical studies in retinal vascular diseases such as diabetic eye disease, RVO and ROP have provided support and understanding for the contributory role of inflammation mediated by VEGFR1/PlGF/VEGF-A.